Patent · US Active

Polynucleotides for preparing ANGPTL 3/8 complexes

US11492395B2 · kind B2 · utility

0Cited by

1References

8Claims

0Family size

Assignee

ELI LILLY AND COMPANY · US

Inventors

Qing Chai · San Diego, US
Jonathan Day · Carmel, US
Robert John Konrad · Carmel, US
Yuewei Qian · Carmel, US
Oliver Schroeder · Encinitas, US
Robert W. Siegel · Beach Park, US

Key dates

Filing date	Jan 19, 2021
Grant date	Nov 8, 2022
Priority date	—
Expiry date	Jan 19, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Angiopoietin-like protein (ANGPTL)3/8 fusion proteins are disclosed. Nucleic acid constructs encoding ANGPTL3/8 fusion proteins also are disclosed. Methods of making and using the same also are disclosed, especially for generating antibodies against ANGPTL3 and/or ANGPTL8.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.